Clinical trial
Effects of Ondansetron in Obsessive-compulsive and Tic Disorders
NCT03239210 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Ondansetron in Obsessive-compulsive and Tic Disorders
- Lead sponsor
- NYU Langone Health
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- June 16, 2017
- Completion date
- May 16, 2022
- Enrollment
- 110 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.